Deschloro Dasatinib-d7

Stable Isotopes API Family: Dasatinib CAT No. CS-T-103888 CAS No. 1184919-23-0(unlabelled)
Enquire
Product Detail

Deschloro Dasatinib-d7

Dasatinib Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category Stable Isotopes
API Family Dasatinib
Storage Refer MSDS for complete information.
Hazard Information Refer MSDS for complete information.

Deschloro Dasatinib-d7 Product Information

Deschloro Dasatinib-d7 is listed under Stable Isotopes. It is associated with Dasatinib and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103888.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
Deschloro Dasatinib-d7
CAS No.
1184919-23-0(unlabelled)
CAT No.
CS-T-103888
Molecular Formula
C₂₂H₂₀D₇N₇O₂S
Molecular Weight
460.6
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
O=C(C1=CN=C(NC2=CC(N3CCN(CCO)CC3)=NC(C)=N2)S1)NC4=C([2H])C([2H])=C([2H])C([2H])=C4C([2H])([2H])[2H]
IUPAC Name
2-[[6-[4-(2-Hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-N-(2-methylphenyl)-5-thiazolecarboxamide-d7
Hazard Compound
Refer MSDS for complete information.

Description

Overview
Deschloro Dasatinib-d7 is the labelled analogue of Deschloro Dasatinib (D289265), the impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product.
Synonyms
2-[[6-[4-(2-Hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-N-(2-methylphenyl)-5-thiazolecarboxamide-d7
Application Notes
Deschloro Dasatinib-d7 is the labelled analogue of Deschloro Dasatinib (D289265), the impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product.
References
Lombardo, L.J., et al: J. Med. Chem., 47, 6658 (2004), Shah, N. P., et al.: Science, 305, 399 (2004), O’Hare, T., et al.: Curr. Opin. Genet. Dev., 16, 92 (2006),
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.